Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor Conference
03 February 2010 - 11:30PM
PR Newswire (US)
SEATTLE, Feb. 3 /PRNewswire-FirstCall/ -- Dendreon Corporation
(NASDAQ: DNDN) today announced that management will present at the
12th Annual BIO CEO and Investor Conference in New York City on
Tuesday, February 9, 2010 at 2:00 p.m. E.T. The presentation will
be audio webcast live and available for replay from Dendreon's
website, http://www.dendreon.com/. If you are unable to listen to
the live webcast, it will be archived on the site following the
presentation. To access the replay, go to the Investor Relations
section of the website. Dendreon Corporation is a biotechnology
company whose mission is to target cancer and transform lives
through the discovery, development and commercialization of novel
therapeutics. The Company applies its expertise in antigen
identification, engineering and cell processing to produce active
cellular immunotherapy product candidates designed to stimulate an
immune response. Dendreon is also developing an orally-available
small molecule that targets TRPM8 that could be applicable to
multiple types of cancer as well as benign prostatic hyperplasia.
The Company has its headquarters in Seattle, Washington and is
traded on the Nasdaq Global Market under the symbol DNDN. For more
information about the Company and its programs, visit
http://www.dendreon.com/. DATASOURCE: Dendreon Corporation CONTACT:
Katherine Stueland, V.P. Corporate Communications & Investor
Relations of Dendreon Corporation, +1-206-829-1522 Web Site:
http://www.dendreon.com/
Copyright